Medical marijuana laws may be connected to increased rates of illicit cannabis use and cannabis use disorder, leading some users to experience negative consequences, such as motor vehicle accidents.
Selective cannabinoids may provide limited relief from chronic neuropathic pain and improvements in quality of life and sleep.
Medical marijuana, as a botanical and a scheduled drug does not fit the FDA paradigm for drug approval, a major impediment to its use in research.
Cannabis use disorder is also rising faster in states with legalization laws
In January 2017, the National Academies of Sciences, Engineering, and Medicine released a report titled “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendation for Research.”
“The utility of the crystal structure may provide inspiration for drug design toward refining efficacy and avoiding adverse events.”
Pot-related poison control calls and hospital discharges spike with wider availability.
Every day the staff at Clinical Pain Advisor browses the Web for stories on chronic pain, acute pain, low back pain, diabetic neuropathy, fibromyalgia and other painful health conditions that readers might have missed the day before and lists some of their favorite articles in a daily column to provide clinicians with a resource they can check first thing in the morning.
Some parents are now demanding that politicians and state legislators legalize the use of marijuana for treating epileptic children.
For Echo, reducing the therapeutic dose is key to improving compliance and providing both patients and healthcare providers with a more cost-effective therapy.
